Mathijs C. Bodde

414 total citations
8 papers, 293 citations indexed

About

Mathijs C. Bodde is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mathijs C. Bodde has authored 8 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mathijs C. Bodde's work include Acute Myocardial Infarction Research (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Mathijs C. Bodde is often cited by papers focused on Acute Myocardial Infarction Research (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Mathijs C. Bodde collaborates with scholars based in Netherlands and United Kingdom. Mathijs C. Bodde's co-authors include J. Wouter Jukema, Sandrin C. Bergheanu, Arnoud van der Laarse, Martin J. Schalij, Christa M. Cobbaert, Willem M. Lijfering, Fred P.H.T.M. Romijn, L. Renee Ruhaak, Diederik W.J. Dippel and Aad van der Lugt and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Atherosclerosis and Clinical Research in Cardiology.

In The Last Decade

Mathijs C. Bodde

7 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathijs C. Bodde Netherlands 6 95 93 57 52 47 8 293
Svetlana Moșteoru Romania 6 78 0.8× 199 2.1× 51 0.9× 49 0.9× 57 1.2× 13 378
Weili Pan China 10 82 0.9× 95 1.0× 55 1.0× 111 2.1× 35 0.7× 26 361
Sergey Kozlov Russia 10 109 1.1× 101 1.1× 53 0.9× 54 1.0× 20 0.4× 49 302
Paymon Azizi Canada 8 129 1.4× 88 0.9× 59 1.0× 94 1.8× 47 1.0× 18 401
Yasuhiko Mitsuke Japan 11 153 1.6× 72 0.8× 39 0.7× 92 1.8× 23 0.5× 21 395
Francesco Maria Adamo Italy 8 110 1.2× 55 0.6× 48 0.8× 83 1.6× 18 0.4× 18 344
Andrzej Kułach Poland 11 136 1.4× 61 0.7× 48 0.8× 104 2.0× 29 0.6× 38 351
Anthony D. Pisaniello Australia 8 106 1.1× 167 1.8× 31 0.5× 41 0.8× 113 2.4× 18 303
Tomoya Hara Japan 9 176 1.9× 68 0.7× 37 0.6× 35 0.7× 19 0.4× 21 364

Countries citing papers authored by Mathijs C. Bodde

Since Specialization
Citations

This map shows the geographic impact of Mathijs C. Bodde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathijs C. Bodde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathijs C. Bodde more than expected).

Fields of papers citing papers by Mathijs C. Bodde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathijs C. Bodde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathijs C. Bodde. The network helps show where Mathijs C. Bodde may publish in the future.

Co-authorship network of co-authors of Mathijs C. Bodde

This figure shows the co-authorship network connecting the top 25 collaborators of Mathijs C. Bodde. A scholar is included among the top collaborators of Mathijs C. Bodde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathijs C. Bodde. Mathijs C. Bodde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Bodde, Mathijs C., Rachid Abou, Bart Mertens, et al.. (2019). Myocardial infarction patients referred to the primary care physician after 1‑year treatment according to a guideline-based protocol have a good prognosis. Netherlands Heart Journal. 27(11). 550–558. 1 indexed citations
4.
Bodde, Mathijs C., J. Wouter Jukema, Martin J. Schalij, et al.. (2018). Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up. Clinical Research in Cardiology. 108(5). 520–538. 51 indexed citations
5.
Bodde, Mathijs C., Paul Welsh, Sandrin C. Bergheanu, et al.. (2018). A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High‐Sensitivity Cardiac Troponin‐I in Subjects With Stable Cardiovascular Disease. Clinical Pharmacology & Therapeutics. 104(2). 311–316. 5 indexed citations
6.
Bodde, Mathijs C., et al.. (2017). Low levels of apolipoprotein-CII in normotriglyceridemic patients with very premature coronary artery disease: Observations from the MISSION! Intervention study. Journal of clinical lipidology. 11(6). 1407–1414. 10 indexed citations
7.
Bergheanu, Sandrin C., Mathijs C. Bodde, & J. Wouter Jukema. (2017). Pathophysiology and treatment of atherosclerosis. Netherlands Heart Journal. 25(4). 231–242. 191 indexed citations
8.
Bodde, Mathijs C., et al.. (2012). Determinants of calcification growth in atherosclerotic carotid arteries; a serial multi-detector CT angiography study. Atherosclerosis. 227(1). 95–99. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026